Articles

18 months ago, a friend told me to buy Dryships. I bought it at $9, before selling it at $9.10 the next day. Today the stock hit $130. I missed it. Here is why I would miss it again.

Intel is a buy on the news and Yahoo! is a sell.

The answer is yes if I a judge how my wife's butt looks in their clothing, but it is less certain when I look at the stock's fundamentals.

Definitely time to sell ERIC, QCOM, NOK, ALA, SI and NT.

Jim Chanos was on CNBC this morning and he says that Macquarie Bank is a house of cards.

Fed Chairman Ben Barnanke gave a speech today to the Economic Club of New York in which he said it was too early to tell if the worst was over from the credit crunch. He had a few other interesting nuggets of insight.

Medtronic has had a bad week- their stock went down on good news regarding their drug eluting stent and now today the stock plummeted on news of the withdrawal from the market of their ICD leads.

I just spent half an hour watching Fox Business and I could have been watching CNBC. The show had the same look, the same mostly polished anchors, the same ticker at the bottom, etc. I think Fox is going to have to do more to take significant market share away from CNBC.

With today's launch of the Fox Business Channel, I no longer need to let these folks into my living room.

If these companies don't hit the ball out of the park this earnings season, then they never will.

The parallels between the crash in 1987 and the one soon to happen in 2007 are too real for comfort. Just look at the derivatives of 87 and the sub-prime mess of 2007. Or, consumer confidence which is barely holding now, but will fall in a NY minute. Or, many other similarities. The point is that again, like 87, we have our heads in the sand.

With all the drugs out there and all the claims on TV and in other ads, wouldn’t it be nice if you could pay only if the drug delivered promised results? Pay for Lipitor, for example, only if it dropped your cholesterol level by 30% or pony up for a pain reducer only if it actually reduced your pain significantly. And, then there are these extremely expensive drugs for major debilitating diseases where no one is sure whether or not they work. The idea that you would pay only if a drug actually delivered as promised is a very sexy idea.

Cramer has spoken about this stock time and time again, and he is always wrong. Last night, he set a new precedent by mispronouncing the stock as "elvaron".